D M Barnes. Show Affiliations »
Abstract
Mesh: See more » 3,4-Methylenedioxyamphetamine/adverse effects3,4-Methylenedioxyamphetamine/analogs & derivatives3,4-Methylenedioxyamphetamine/therapeutic use3,4-Methylenedioxyamphetamine/toxicityAmphetamines/adverse effectsAmphetamines/therapeutic useAmphetamines/toxicityAnimalsBrain/pathologyHaplorhiniHumansLegislation, DrugN-Methyl-3,4-methylenedioxyamphetamineNervous System Diseases/chemically inducedNervous System Diseases/pathologyNeurons/metabolismNeurons/pathologyPsychotherapyRatsSerotonin/metabolismSubstance-Related Disorders
Substances: See more » AmphetaminesSerotonin3,4-MethylenedioxyamphetamineN-Methyl-3,4-methylenedioxyamphetamine
Year: 1988 PMID: 2893452 DOI: 10.1126/science.2893452
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728